Insider Trading disclosures for Eton Pharmaceuticals Inc

The latest disclosure was made by David C. Krempa in Eton Pharmaceuticals Inc where a trade of 38,621 Employee Stock Option (Right to Buy) done was reported to US exchanges on Jan. 3, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Show

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
David C. Krempa	Chief Business Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2025	38,621	38,621	-		-	Employee Stock Option (Right to Buy)
Charles J. Casamento	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2025	25,000	25,000	-		-	Employee Stock Option (Right to Buy)
Norbert G. Riedel	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 Jan 2025	27,400	0	-		-	Employee Stock Option (Right to Buy)
Norbert G. Riedel	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2025	25,000	25,000	-		-	Employee Stock Option (Right to Buy)
Norbert G. Riedel	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.78 per share.	03 Jan 2025	50,000	137,145 (0%)	0%	3.8	189,000	Common Stock
Norbert G. Riedel	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.47 per share.	03 Jan 2025	25,000	162,145 (0%)	0%	3.5	86,750	Common Stock
Norbert G. Riedel	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 Jan 2025	25,000	0	-		-	Employee Stock Option (Right to Buy)
Norbert G. Riedel	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 Jan 2025	50,000	0	-		-	Employee Stock Option (Right to Buy)
Norbert G. Riedel	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.58 per share.	03 Jan 2025	27,400	87,145 (0%)	0%	3.6	98,092	Common Stock
Sean E. Brynjelsen	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2025	107,469	107,469	-		-	Employee Stock Option (Right to Buy)
Sean E. Brynjelsen	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2025	72,004	72,004	-		-	Restricted Stock Units
Jennifer McKie Adams	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2025	25,000	25,000	-		-	Employee Stock Option (Right to Buy)
James R. Gruber	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2025	25,876	25,876	-		-	Restricted Stock Units
James R. Gruber	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2025	38,621	38,621	-		-	Employee Stock Option (Right to Buy)
David C. Krempa	Chief Business Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2025	25,876	25,876	-		-	Restricted Stock Units
Paul Victor Maier	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2025	25,000	25,000	-		-	Employee Stock Option (Right to Buy)
David C. Krempa	Chief Business Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Oct 2024	42,088	861,374	-		-	Restricted Stock Units
Krempa C. David	Chief Business Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2024	144,677	813,430	-		-	Stock Option (Right to buy)
Charles Casamento J.	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2024	30,000	164,555	-		-	Stock Option (Right to buy)
R. Gruber James	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2024	144,677	374,763	-		-	Stock Option (Right to buy)
Paul Maier Victor	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2024	30,000	164,555	-		-	Stock Option (Right to buy)
Riedel Norbert G.	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2024	30,000	164,555	-		-	Stock Option (Right to buy)
Sean Brynjelsen E.	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2024	438,633	2,473,014	-		-	Stock Option (Right to buy)
McKie Adams Jennifer	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2024	30,000	133,133	-		-	Stock Option (Right to buy)
James R. Gruber	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Mar 2023	100,086	200,086	-		-	Stock Option (right to buy)
Jennifer McKie Adams	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Mar 2023	25,000	103,133	-		-	Stock Option (Right to buy)
Sean E. Brynjelsen	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Mar 2023	350,381	1,951,881	-		-	Stock Option (Right to buy)
Paul Victor Maier	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Mar 2023	25,000	134,555	-		-	Stock Option(Right to buy)
Norbert G. Riedel	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Mar 2023	25,000	134,555	-		-	Stock Option (Right to buy)
Charles J. Casamento	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Mar 2023	25,000	134,555	-		-	Stock Option (Right to buy)
Sean E. Brynjelsen	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 2.10 per share.	22 Sep 2022	10,000	1,040,000 (5%)	0%	2.1	21,042	Common Stock
James R. Gruber	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jul 2022	40,000	40,000	-		-	Restricted Stock Units
Sean E. Brynjelsen	Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jul 2022	110,000	110,000	-		-	Restricted Stock Units
Charles J. Casamento	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Feb 2022	50,000	109,555	-		-	Stock Option (Right to buy)
Norbert G. Riedel	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Feb 2022	50,000	109,555	-		-	Stock Option (Right to buy)
Paul Victor Maier	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Feb 2022	50,000	109,555	-		-	Stock Option(Right to buy)
Sean E. Brynjelsen	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Feb 2022	416,500	1,601,500	-		-	Stock Option(Right to buy)
W. Wilson Troutman	CFO and Secretary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Feb 2022	15,000	671,200	-		-	Stock Option (Right to buy)
Jennifer McKie Adams	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Feb 2022	50,000	78,133	-		-	Stock Option (Right to buy)
Sean E. Brynjelsen	Director, President & CEO	Purchase of securities on an exchange or from another person at price $ 4.32 per share.	20 Aug 2021	10,000	1,030,000 (5%)	0%	4.3	43,200	Common Stock
W. Wilson Troutman	CFO, Treasurer & Secretary	Purchase of securities on an exchange or from another person at price $ 4.43 per share.	20 Aug 2021	5,000	23,027 (0%)	0%	4.4	22,150	Common Stock
Sean E. Brynjelsen	Director, President & CEO	Purchase of securities on an exchange or from another person at price $ 5.96 per share.	03 Jun 2021	5,000	1,030,000 (5%)	0%	6.0	29,800	Common Stock
Jennifer McKie Adams	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 May 2021	28,133	28,133	-		-	Stock Option (Right to buy)
W. Wilson Troutman	CFO and Secretary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 May 2021	125,000	656,200	-		-	Stock Option(Right to buy)
Charles J. Casamento	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 May 2021	19,655	59,555	-		-	Stock Option (Right to buy)
Norbert G. Riedel	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 May 2021	19,655	59,555	-		-	Stock Option (Right to buy)
Paul Victor Maier	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 May 2021	19,655	59,555	-		-	Stock Option(Right to buy)
Sean E. Brynjelsen	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 May 2021	245,000	1,185,000	-		-	Stock Option(Right to buy)
Charles J. Casamento	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Mar 2020	27,400	27,400	-		-	Stock Option (Right to buy)
Mark L. Baum	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Mar 2020	27,400	27,400	-		-	Stock Option (Right to buy)

Showing 1 to 50 of 74 entries

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

382.51% Gain from 52W Low

Insider Trading disclosures for Eton Pharmaceuticals Inc

The latest disclosure was made by David C. Krempa in Eton Pharmaceuticals Inc where a trade of 38,621 Employee Stock Option (Right to Buy) done was reported to US exchanges on Jan. 3, 2025.

Screeners based on Insider Trading and SAST parameters